Scarica l'app Stockscreener
2.98
2.61%
-0.08
Femasys Inc Borsa (FEMY) Ultime notizie
Femasys (FEMY): Moves 0.74% Higher to $2.73 for the Current Session; the Session Ends Within the Reported Technical Boundaries in Latest TradingVolatility Smirk - vinanet.vn
Biotech Femasys (NASDAQ: FEMY) raises $30M in private round - Stock Titan
Femasys Secures FDA Pathway for Non-Surgical Contraceptive - Sahm
Femasys Jumps as FDA Clears Modular Review Path for Non-Surgical Birth Control - finance.biggo.com
Why Is Femasys Stock Soaring Today?Femasys (NASDAQ:FEMY) - Benzinga
FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential - TradingView
Femasys receives FDA approval for modular PMA pathway for FemBloc By Investing.com - Investing.com Nigeria
Femasys (FEMY) Results Versus Estimates: EPS Beats Its Estimate in the Latest Reading; Latest Reaction: Shares Move 24.32% Up for the Current SessionLow Growth Earnings - Vinanet
Femasys Secures FDA Approval for Modular PMA Pathway for FemBloc - Yahoo Finance
FDA approves a modular review path for Femasys’ permanent birth control - Stock Titan
Femasys receives FDA approval for modular PMA pathway for FemBloc - Investing.com
Femasys Inc. Announces FDA Approval of Modular PMA Pathway for FemBloc in the U.S. - Quiver Quantitative
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc® - Caledonian Record
Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc - TradingView
Femasys secures $30 million to advance fertility portfolio - The Pharma Letter
Nantahala's $12M deal brings board influence at Femasys (NASDAQ: FEMY) - Stock Titan
FEMY Q1 2026 Earnings: Loss Beat Estimates, Stock Slips 1.31%Earnings Turnaround - vinanet.vn
Femasys earnings missed by $0.20, revenue fell short of estimates - Investing.com Canada
Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Femasys 2Q Loss/Shr $1.33 >FEMY - Moomoo
Femasys Stock Price Forecast. Should You Buy FEMY? - StockInvest.us
Femasys Q2 EPS $(1.08) beats estimate; sales rise 85% - scanx.trade
Femasys (NASDAQ: FEMY) cuts net loss and secures $30M private funding - Stock Titan
Femasys reports $331,827 Q2 revenue, $4.47M net loss and $30M financing to support U.S. commercial push - TradingView
Femasys Reports $331,827 Q2 Revenue and $4.47 Million Net Loss - Quiver Quantitative
Femasys Inc. (NASDAQ: FEMY) narrows first-half loss, completes $30M financing - Stock Titan
Femasys Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Femasys (FEMY) gains Rosalind-linked holder with potential 9.99% equity stake - Stock Titan
FEMY Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Slips 2.55%Earnings Decline Risk - vinanet.vn
FEMY Q1 2026 Earnings: Narrower-Than-Expected Loss of -$1.20 Per Share, Yet Shares Dip 2.34%ROIC Trend Report - Vinanet
Femasys Strengthens and Extends Global Patent Protection for FemBloc with First Issued Blended Polymer Patents - marketscreener.com
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower-Than-Expected Loss of -$1.20 Per Share Beats Estimates by 34.64% - dars.gov.et
Femasys receives patents for FemBloc birth control polymer By Investing.com - Investing.com South Africa
Femasys receives patents for FemBloc birth control polymer - Investing.com
Femasys Secures New U.S. and International Patents for FemBloc Blended Polymer, Expanding Global IP Protection - Quiver Quantitative
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents - Yahoo Finance
Femasys COO John Canning buys $14,000 in FEMY stock By Investing.com - Investing.com Australia
Femasys COO John Canning buys $14,000 in FEMY stock - Investing.com India
Femasys chief clinical-medical affairs Mifek buys $10,000 stock By Investing.com - Investing.com Australia
Femasys CFO Dov Elefant buys $50,000 in company stock By Investing.com - Investing.com South Africa
Femasys CTO Jeremy Sipos buys $10,000 in common stock - Investing.com India
Femasys CEO Kathy Lee-Sepsick buys $50,000 in FEMY stock By Investing.com - Investing.com Australia
Femasys CFO Dov Elefant buys $50,000 in company stock - Investing.com
Femasys chief clinical-medical affairs Mifek buys $10,000 stock - Investing.com
Femasys CTO Jeremy Sipos buys $10,000 in common stock By Investing.com - Investing.com Australia
Femasys CEO Kathy Lee-Sepsick buys $50,000 in FEMY stock - Investing.com
Form 8K Femasys Inc For: 11 August By Investing.com - Investing.com South Africa
Femasys completes $30 million private placement financing - TipRanks
0.76%
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):